Because CerS2 null livers display CD36 mislocalization and insulin receptor dysfunction with altered detergent-resistant membranes7,21, CerS2 null livers did not develop NAFLD during HFD7 despite an increased hepatic ER stress response (Supplementary Fig. 2). This evidence concerns the gene CERS2 and metabolic dysfunction-associated steatotic liver disease.